Visit https://www.peervoice.com/DKF860 to view the entire programme with slides. After completing “Optimising Outcomes With PARPs in Advanced Ovarian Cancer”, participants will be able to: Describe the latest clinical findings for PARP inhibitors in the management of advanced ovarian cancer; Summarise the clinical implications of these emerging data in the management of advanced ovarian cancer; Translate clinical evidence for PARP inhibitors in advanced ovarian cancer into optimal treatment plans